Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TNBC - Triple-Negative Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03219268
What this trial is testing

MGD013 in Patients With Unresectable or Metastatic Neoplasms

Who this might be right for
Advanced Solid TumorsHematologic NeoplasmsOvarian Cancer+7 more
MacroGenics 277
Early research (Phase 1)Study completedNCT04293094
What this trial is testing

Study of AMG 650 in Adult Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Volastra Therapeutics, Inc. 66
Testing effectiveness (Phase 2)Study completedNCT02413320
What this trial is testing

Neoadjuvant Study of Two Platinum Regimens in Triple Negative Breast Cancer

Who this might be right for
Triple-negative Breast Cancer
Priyanka Sharma 101
Not applicableLooking for participantsNCT03017573
What this trial is testing

Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)

Who this might be right for
Ovarian CancerTriple-Negative Breast CancerHead and Neck Cancer+3 more
Institut Curie 1,050
Testing effectiveness (Phase 2)Study completedNCT04224922
What this trial is testing

Phase II Study of Neoadjuvant Weekly Paclitaxel and Carboplatin Followed by Dose Dense Epirubicin and Cyclophosphamide in Stage II and III Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Universitair Ziekenhuis Brussel 63
Not applicableWithdrawnNCT06610097
What this trial is testing

TNBC Gut Microbiota During Neoadjuvant Treatment

Who this might be right for
Breast CancerTriple Negative Breast CancerEarly Stage Triple-Negative Breast Carcinoma
Scripps Health
Testing effectiveness (Phase 2)Ended earlyNCT00817531
What this trial is testing

Efficacy Study of Dasatinib in Locally Advanced Triple-Negative Breast Cancer Patients

Who this might be right for
Breast Cancer
Baylor Breast Care Center 22
Testing effectiveness (Phase 2)Study completedNCT03304756
What this trial is testing

Study of Neoadjuvant Treatment of Locally Advanced Breast Cancer With CAP Regimen

Who this might be right for
Triple Negative Breast Cancer Patients
Instituto Nacional de Cancer, Brazil 41
Testing effectiveness (Phase 2)Study completedNCT01091454
What this trial is testing

Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Triple-negative Breast Cancer
Alliance for Clinical Trials in Oncology 48
Testing effectiveness (Phase 2)Ended earlyNCT04216472
What this trial is testing

Nab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN Alterations

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+19 more
M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)Looking for participantsNCT06385990
What this trial is testing

Utidelone (UTD1) Plus Capecitabine in Non-pCR TNBC After Neoadjuvant Therapy

Who this might be right for
Triple Negative Breast Neoplasms
Hunan Cancer Hospital 53
Large-scale testing (Phase 3)Study completedNCT04085276
What this trial is testing

Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment

Who this might be right for
Triple-Negative Breast Cancer
Shanghai Junshi Bioscience Co., Ltd. 531
Very early researchLooking for participantsNCT06305962
What this trial is testing

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

Who this might be right for
PDL1 Gene MutationNon Small Cell Lung CancerSmall Cell Lung Cancer ( SCLC )+6 more
Radiopharm Theranostics, Ltd 30
Large-scale testing (Phase 3)UnknownNCT02595138
What this trial is testing

Zoledronic Acid as Adjuvant Treatment of Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Chinese Academy of Medical Sciences 430
Not applicableLooking for participantsNCT07073755
What this trial is testing

Real-World Study of Post-Resistance Treatment Strategies in Advanced Breast Cancer Following CDK4/6i, PIK3CA Inhibitors, or T-DXd

Who this might be right for
Metastatic Breast CancerDrug ResistanceHormone Receptor-Positive Breast Cancer+3 more
Hunan Cancer Hospital 200
Large-scale testing (Phase 3)Not Yet RecruitingNCT07407517
What this trial is testing

Adjuvant Intensification for LAR

Who this might be right for
Breast Cancer FemalesTriple Negative Breast Cancer (TNBC)
Fudan University 904
Large-scale testing (Phase 3)Study completedNCT01805076
What this trial is testing

MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer

Who this might be right for
Estrogen Receptor-negative Breast CancerProgesterone Receptor-negative Breast CancerStage IA Breast Cancer+3 more
Alliance for Clinical Trials in Oncology 319
Testing effectiveness (Phase 2)Study completedNCT00834678
What this trial is testing

Bendamustine and Erlotinib in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
Ohio State University Comprehensive Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT03577743
What this trial is testing

Effect of Bevacizumab in Metastatic Triple Negative Breast Cancer

Who this might be right for
Metastatic Triple Negative Breast CancerSafety IssuesEfficacy
Assiut University 54
Not applicableStudy completedNCT05730010
What this trial is testing

Discerning the Impact of ctDNA Detection on Patient Decision Making in Early Stage Breast Cancer: a Conjoint Analysis

Who this might be right for
Triple Negative Breast Cancer
Indiana University 289
Next Page